Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

434
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
434
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

57
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
57
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

358
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
358
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

486
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creating a Coordinated Complex Outpatient Antibiotic Therapy Program to Improve Outcomes and Reduce Costs in a Multihospital System.

NEJM catalyst innovations in care delivery·2026
Same author

Stigmatising language in research and clinical care for body-focused repetitive behaviours.

The lancet. Psychiatry·2026
Same author

Trends in HCV Prevalence and Risk Factors Among People who Inject Drugs in Los Angeles County, 2012-2024.

AIDS and behavior·2026
Same author

It's time to stop rounding serum creatinine.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Toddler With Recurrent Episodes of Loss of Consciousness.

Pediatrics in review·2025
Same author

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.

Clinical pharmacology and therapeutics·2025

Related Experiment Video

Updated: Mar 13, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

The 2016 ACCP Pharmacotherapy Didactic Curriculum Toolkit.

Terry L Schwinghammer1, Andrew J Crannage1, Eric G Boyce1

  • 1American College of Clinical Pharmacy.

Pharmacotherapy
|November 3, 2016
PubMed
Summary
This summary is machine-generated.

The updated Pharmacotherapy Didactic Curriculum Toolkit guides pharmacy schools in curriculum development. It categorizes 276 topics into tiers based on practice competency, emphasizing foundational knowledge and postgraduate training needs.

Keywords:
accreditationcurriculumdisease statespharmacotherapypharmacy educationpractice competency

More Related Videos

Mechanical Ventilation Boot Camp Curriculum
07:36

Mechanical Ventilation Boot Camp Curriculum

Published on: March 12, 2018

10.8K
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

5.0K

Related Experiment Videos

Last Updated: Mar 13, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K
Mechanical Ventilation Boot Camp Curriculum
07:36

Mechanical Ventilation Boot Camp Curriculum

Published on: March 12, 2018

10.8K
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

5.0K

Area of Science:

  • Pharmacy Education
  • Pharmacotherapy
  • Curriculum Development

Background:

  • The American College of Clinical Pharmacy (ACCP) Educational Affairs Committee updated its 2009 Pharmacotherapy Didactic Curriculum Toolkit in 2016.
  • The toolkit aims to assist pharmacy schools in creating, maintaining, and revising their educational programs.

Purpose of the Study:

  • To contemporize the ACCP's Pharmacotherapy Didactic Curriculum Toolkit.
  • To identify and organize disease states and content topics responsive to drug therapy for pharmacy curricula.

Main Methods:

  • Reviewed recent medical literature and relevant documents.
  • Organized identified disease states and content topics by organ system.
  • Grouped topics into three tiers based on practice competency levels.

Main Results:

  • The 2016 toolkit includes 276 diseases and content topics.
  • Tier 1 (foundational): 87 topics (32%) for immediate post-graduation patient care.
  • Tier 2 (intermediate): 133 topics (48%) often requiring postgraduate training.
  • Tier 3 (advanced): 56 topics (20%) typically requiring self-study post-graduation.

Conclusions:

  • The updated toolkit provides a comprehensive framework for pharmacotherapy education.
  • A significant number of Tier 1 topics necessitate innovative teaching strategies for competency.
  • The high proportion of Tier 2 topics underscores the critical role of residency training for advanced patient care skills.